Endocrine Pharmaceuticals Limited
03005721
Healthy
No risk factors detected.
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 22/05/1995
BUSINESS DEVELOPMENT SPECIALIS
BRITISH · ENGLAND · Age 72
director · Since 13/01/2014
FARMER
BRITISH · ENGLAND · Age 80
Also on 8 other boards
Persons with Significant Control
Dr John Ernest Hart
British · England · Age 72
Wilderness End, Common Road, Tadley, RG26 3TA
Notified 05/01/2017
CompanyRankvs 2393+ SIC 72190 peers60
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 30/06/2025
Net Worth
£22k
Balance sheet strength
Cash
£2k
Cash in the bank
Net Current Assets
-£99k
Working capital
Current Assets
—
Current Liabilities
£101k
Profit After Tax
-£11k
Balance Sheet
EstimatesDerived
| Year | Implied Profit |
|---|---|
| 2025 | +£112k |
| 2024 | -£111k |
| 2023 | +£0 |
| 2022 | +£500 |
| 2021 | +£500 |
| 2020 | +£250 |
Derived from filed accounts. Not audited figures.